ECHELON-3
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Loading…
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Loading…